Tours, 20-22 November 2012, Vinci Centre International de Congrès
Header

Home

Therapeutic Antibodies and Infectious Diseases

Tours, France, 20-22 November 2012

Dear Friends, Dear Colleagues,

On behalf of the GDR 3260 “Antibodies and therapeutic targeting”, the Laboratory of Excellence (LabEx) “MAbImprove”,  the Cluster de recherche en infectiologie and the Fédération de recherche en infectiologie, I am pleased to announce that the first  congress on “Therapeutic Antibodies and Infectious Diseases will be held in Tours from the 20th to the 22nd of November 2012. Therefore, I would like to take the present opportunity to invite you to join us for that meeting.

We are living an exciting scientific period, with monoclonals antibodies inducing considerable advances in the field of infectious diseases.  However, there is a constant need to gather specialists of multiple disciplines to confront what has been learned from clinical experience and from recent pre-clinical and clinical developments.

With the Local Organizing and Scientific Committees, our aim is to build an ambitious and unique program focused on the targeting of microorganisms and their human receptors and the way currently approved monoclonals influence infectious diseases. During this 3 days congress, we will bring together scientific and clinical leaders from all over the world, in order to lead lively and interactive debates. The congress will take place in the modern “Vinci International Congress Centre” strategically located near the TGV fast train station, in the heart of Tours.

In addition to an exciting scientific program, you will benefit from the cultural background and historical landscape that make Tours and its nearest areas (Chenonceau, Villandry, Amboise among many others), one of the most attractive places in France, and this should also contribute towards making this event an unforgettable moment.

I look forward to welcoming and hosting you in Tours in November 2012, and sincerely hope that you will join us to make this endeavour a success.

 

Pr Hervé Watier